company background image
A150840 logo

IntroMedic KOSDAQ:A150840 Stock Report

Last Price

₩5.85k

Market Cap

₩223.7b

7D

0%

1Y

136.4%

Updated

11 Jun, 2022

Data

Company Financials

IntroMedic Co., Ltd.

KOSDAQ:A150840 Stock Report

Market Cap: ₩223.7b

A150840 Stock Overview

IntroMedic Co., Ltd. develops and supplies medical equipment in South Korea and internationally.

A150840 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

IntroMedic Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IntroMedic
Historical stock prices
Current Share Price₩5,850.00
52 Week High₩8,220.00
52 Week Low₩2,460.00
Beta0.40
1 Month Change0%
3 Month Change-4.26%
1 Year Change136.36%
3 Year Change6.36%
5 Year Change70.31%
Change since IPO105.26%

Recent News & Updates

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

Mar 11
IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

Recent updates

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

Mar 11
IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

Jan 17
IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Nov 24
What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Shareholder Returns

A150840KR Medical EquipmentKR Market
7D0%3.2%2.4%
1Y136.4%38.0%12.2%

Return vs Industry: A150840 exceeded the KR Medical Equipment industry which returned 10.8% over the past year.

Return vs Market: A150840 exceeded the KR Market which returned 8% over the past year.

Price Volatility

Is A150840's price volatile compared to industry and market?
A150840 volatility
A150840 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.7%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.9%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A150840 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine A150840's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200454Yong Seok Chohttps://www.intromedic.com

IntroMedic Co., Ltd. develops and supplies medical equipment in South Korea and internationally. It offers MiroCam, a capsule endoscope system; E.G. Scan, a disposable ductile esophagoscope; and EndoClot, an absorbent hemostasis equipment.

IntroMedic Co., Ltd. Fundamentals Summary

How do IntroMedic's earnings and revenue compare to its market cap?
A150840 fundamental statistics
Market cap₩223.67b
Earnings (TTM)-₩15.52b
Revenue (TTM)₩8.01b

27.9x

P/S Ratio

-14.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A150840 income statement (TTM)
Revenue₩8.01b
Cost of Revenue₩3.43b
Gross Profit₩4.59b
Other Expenses₩20.11b
Earnings-₩15.52b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-405.99
Gross Margin57.23%
Net Profit Margin-193.75%
Debt/Equity Ratio16.3%

How did A150840 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.